US Stock MarketDetailed Quotes

ORMP Oramed Pharmaceuticals

Watchlist

2.465
+0.095+4.01%

Close Dec 2 16:00 ET

2.471
+0.006+0.26%

Post 17:05 ET

99.37MMarket Cap22.41P/E (TTM)

Oramed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-923.20%-7.1M

178.82%2.08M

73.40%-1.48M

63.12%-10.3M

82.41%-1.42M

69.03%-694K

68.98%-2.63M

39.19%-5.55M

-151.02%-27.92M

-31.26%-8.06M

Net income from continuing operations

-498.11%-19.64M

800.99%9.2M

142.48%1.53M

113.47%5.09M

252.20%13.3M

54.72%-3.28M

88.14%-1.31M

66.28%-3.61M

-208.15%-37.76M

-21.57%-8.74M

Operating gains losses

-279.81%-6.02M

377.97%3.86M

99.45%-7K

-39.16%-2.18M

79.21%-131K

-158.14%-1.59M

1,061.90%808K

-439.15%-1.27M

-4,497.06%-1.56M

-1,385.71%-630K

Depreciation and amortization

-3.70%52K

3.85%54K

51.35%56K

237.93%196K

211.76%53K

260.00%54K

246.67%52K

236.36%37K

222.22%58K

-10.53%17K

Other non cash items

--0

---1.48M

--21K

6,590.91%1.47M

--650K

----

--22K

----

Change In working capital

-10.40%1.63M

167.22%2.18M

23.28%-626K

-185.90%-2.7M

70.88%-452K

-25.55%1.82M

-1,263.44%-3.25M

61.36%-816K

-34.91%-943K

-1,537.04%-1.55M

-Change in prepaid assets

-44.34%59K

-104.89%-32K

205.88%36K

217.91%852K

116.45%126K

-68.36%106K

-34.21%654K

88.47%-34K

158.26%268K

-629.52%-766K

-Change in payables and accrued expense

-10.42%1.55M

168.68%2.22M

-546.60%-666K

-491.76%-2.23M

-1,256.52%-624K

138.54%1.73M

-3,424.74%-3.23M

91.05%-103K

-154.57%-376K

-104.96%-46K

-Change in other current liabilities

--0

-142.86%-3K

--0

105.26%2K

102.86%2K

-107.14%-5K

118.42%7K

---2K

-52.00%-38K

-94.44%-70K

-Change in other working capital

330.00%23K

100.29%2K

100.59%4K

-66.25%-1.33M

106.57%44K

-100.76%-10K

11.89%-682K

-1.65%-677K

11.74%-797K

1.33%-670K

Cash from discontinued investing activities

Operating cash flow

-923.20%-7.1M

178.82%2.08M

73.40%-1.48M

63.12%-10.3M

82.41%-1.42M

69.03%-694K

68.98%-2.63M

39.19%-5.55M

-151.02%-27.92M

-31.26%-8.06M

Investing cash flow

Cash flow from continuing investing activities

54.39%-34.26M

743.47%94.66M

327.21%30M

-341.76%-73.04M

166.40%30M

-6,212.45%-75.12M

-241.95%-14.71M

-279.41%-13.2M

130.44%30.21M

138.76%11.26M

Net PPE purchase and sale

84.38%-5K

--0

98.99%-2K

46.19%-254K

98.94%-3K

73.55%-32K

0.00%-20K

-323.40%-199K

-5,144.44%-472K

-951.85%-284K

Net investment purchase and sale

54.38%-34.26M

744.35%94.66M

330.70%30M

-337.23%-72.78M

159.85%30M

-5,662.22%-75.09M

-241.52%-14.69M

-275.59%-13M

130.92%30.68M

139.78%11.55M

Net other investing changes

----

--2K

---1K

Cash from discontinued investing activities

Investing cash flow

54.39%-34.26M

743.47%94.66M

327.21%30M

-341.76%-73.04M

166.40%30M

-6,212.45%-75.12M

-241.95%-14.71M

-279.41%-13.2M

130.44%30.21M

138.76%11.26M

Financing cash flow

Cash flow from continuing financing activities

-101.73%-1.29M

-30.55M

-881.89%-19M

382.22%51.98M

-698.80%-25M

1,628.45%74.55M

6.02%2.43M

-82.20%10.78M

-92.41%4.18M

Net issuance payments of debt

--0

---30.55M

---19M

--49.55M

---25M

--74.55M

--0

Net common stock issuance

-64,450.00%-1.29M

--0

-78.89%2.43M

--0

-100.05%-2K

--0

-18.15%2.43M

-80.81%11.5M

-89.31%4.16M

Proceeds from stock option exercised by employees

----

--0

----

-90.30%62K

-99.86%20K

Net other financing activities

----

---783K

--0

Cash from discontinued financing activities

Financing cash flow

-101.73%-1.29M

---30.55M

-881.89%-19M

382.22%51.98M

-698.80%-25M

1,628.45%74.55M

--0

6.02%2.43M

-82.20%10.78M

-92.41%4.18M

Net cash flow

Beginning cash position

1,152.45%84.75M

-22.93%18.58M

-77.62%9.06M

47.38%40.46M

-83.53%5.47M

-77.36%6.77M

-13.81%24.1M

47.38%40.46M

-64.46%27.46M

-42.18%33.2M

Current changes in cash

-3,263.72%-42.65M

481.58%66.18M

158.34%9.52M

-339.86%-31.36M

-51.46%3.58M

-138.41%-1.27M

-1,026.50%-17.34M

-3,203.04%-16.32M

126.25%13.07M

-62.83%7.37M

Effect of exchange rate changes

109.68%3K

-157.14%-4K

97.37%-1K

15.63%-54K

107.62%8K

-1,133.33%-31K

-86.79%7K

-153.33%-38K

-811.11%-64K

-3,400.00%-105K

End cash Position

670.01%42.1M

1,152.45%84.75M

-22.93%18.58M

-77.62%9.06M

-83.53%5.47M

-77.36%6.77M

-13.81%24.1M

47.38%40.46M

-47.62%40.46M

Free cash flow

-878.79%-7.11M

178.22%2.08M

74.29%-1.48M

62.87%-10.55M

83.02%-1.42M

69.26%-726K

68.81%-2.65M

37.33%-5.75M

-155.27%-28.41M

-35.68%-8.37M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-923.20%-7.1M	178.82%2.08M	73.40%-1.48M	63.12%-10.3M	82.41%-1.42M	69.03%-694K	68.98%-2.63M	39.19%-5.55M	-151.02%-27.92M	-31.26%-8.06M
Net income from continuing operations	-498.11%-19.64M	800.99%9.2M	142.48%1.53M	113.47%5.09M	252.20%13.3M	54.72%-3.28M	88.14%-1.31M	66.28%-3.61M	-208.15%-37.76M	-21.57%-8.74M
Operating gains losses	-279.81%-6.02M	377.97%3.86M	99.45%-7K	-39.16%-2.18M	79.21%-131K	-158.14%-1.59M	1,061.90%808K	-439.15%-1.27M	-4,497.06%-1.56M	-1,385.71%-630K
Depreciation and amortization	-3.70%52K	3.85%54K	51.35%56K	237.93%196K	211.76%53K	260.00%54K	246.67%52K	236.36%37K	222.22%58K	-10.53%17K
Other non cash items	--0	---1.48M	--21K	6,590.91%1.47M	--650K	----	----	----	--22K	----
Change In working capital	-10.40%1.63M	167.22%2.18M	23.28%-626K	-185.90%-2.7M	70.88%-452K	-25.55%1.82M	-1,263.44%-3.25M	61.36%-816K	-34.91%-943K	-1,537.04%-1.55M
-Change in prepaid assets	-44.34%59K	-104.89%-32K	205.88%36K	217.91%852K	116.45%126K	-68.36%106K	-34.21%654K	88.47%-34K	158.26%268K	-629.52%-766K
-Change in payables and accrued expense	-10.42%1.55M	168.68%2.22M	-546.60%-666K	-491.76%-2.23M	-1,256.52%-624K	138.54%1.73M	-3,424.74%-3.23M	91.05%-103K	-154.57%-376K	-104.96%-46K
-Change in other current liabilities	--0	-142.86%-3K	--0	105.26%2K	102.86%2K	-107.14%-5K	118.42%7K	---2K	-52.00%-38K	-94.44%-70K
-Change in other working capital	330.00%23K	100.29%2K	100.59%4K	-66.25%-1.33M	106.57%44K	-100.76%-10K	11.89%-682K	-1.65%-677K	11.74%-797K	1.33%-670K
Cash from discontinued investing activities
Operating cash flow	-923.20%-7.1M	178.82%2.08M	73.40%-1.48M	63.12%-10.3M	82.41%-1.42M	69.03%-694K	68.98%-2.63M	39.19%-5.55M	-151.02%-27.92M	-31.26%-8.06M
Investing cash flow
Cash flow from continuing investing activities	54.39%-34.26M	743.47%94.66M	327.21%30M	-341.76%-73.04M	166.40%30M	-6,212.45%-75.12M	-241.95%-14.71M	-279.41%-13.2M	130.44%30.21M	138.76%11.26M
Net PPE purchase and sale	84.38%-5K	--0	98.99%-2K	46.19%-254K	98.94%-3K	73.55%-32K	0.00%-20K	-323.40%-199K	-5,144.44%-472K	-951.85%-284K
Net investment purchase and sale	54.38%-34.26M	744.35%94.66M	330.70%30M	-337.23%-72.78M	159.85%30M	-5,662.22%-75.09M	-241.52%-14.69M	-275.59%-13M	130.92%30.68M	139.78%11.55M
Net other investing changes	----	----	----	----	----	----	----	----	--2K	---1K
Cash from discontinued investing activities
Investing cash flow	54.39%-34.26M	743.47%94.66M	327.21%30M	-341.76%-73.04M	166.40%30M	-6,212.45%-75.12M	-241.95%-14.71M	-279.41%-13.2M	130.44%30.21M	138.76%11.26M
Financing cash flow
Cash flow from continuing financing activities	-101.73%-1.29M	-30.55M	-881.89%-19M	382.22%51.98M	-698.80%-25M	1,628.45%74.55M	0	6.02%2.43M	-82.20%10.78M	-92.41%4.18M
Net issuance payments of debt	--0	---30.55M	---19M	--49.55M	---25M	--74.55M	--0	--0	--0	--0
Net common stock issuance	-64,450.00%-1.29M	--0	--0	-78.89%2.43M	--0	-100.05%-2K	--0	-18.15%2.43M	-80.81%11.5M	-89.31%4.16M
Proceeds from stock option exercised by employees	----	----	----	--0	----	----	----	----	-90.30%62K	-99.86%20K
Net other financing activities	----	----	----	----	----	----	----	----	---783K	--0
Cash from discontinued financing activities
Financing cash flow	-101.73%-1.29M	---30.55M	-881.89%-19M	382.22%51.98M	-698.80%-25M	1,628.45%74.55M	--0	6.02%2.43M	-82.20%10.78M	-92.41%4.18M
Net cash flow
Beginning cash position	1,152.45%84.75M	-22.93%18.58M	-77.62%9.06M	47.38%40.46M	-83.53%5.47M	-77.36%6.77M	-13.81%24.1M	47.38%40.46M	-64.46%27.46M	-42.18%33.2M
Current changes in cash	-3,263.72%-42.65M	481.58%66.18M	158.34%9.52M	-339.86%-31.36M	-51.46%3.58M	-138.41%-1.27M	-1,026.50%-17.34M	-3,203.04%-16.32M	126.25%13.07M	-62.83%7.37M
Effect of exchange rate changes	109.68%3K	-157.14%-4K	97.37%-1K	15.63%-54K	107.62%8K	-1,133.33%-31K	-86.79%7K	-153.33%-38K	-811.11%-64K	-3,400.00%-105K
End cash Position	670.01%42.1M	1,152.45%84.75M	-22.93%18.58M	-77.62%9.06M	-77.62%9.06M	-83.53%5.47M	-77.36%6.77M	-13.81%24.1M	47.38%40.46M	-47.62%40.46M
Free cash flow	-878.79%-7.11M	178.22%2.08M	74.29%-1.48M	62.87%-10.55M	83.02%-1.42M	69.26%-726K	68.81%-2.65M	37.33%-5.75M	-155.27%-28.41M	-35.68%-8.37M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data